The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes

Christel Hendrieckx; Hanafi M Husin; Sienna Russell-Green; Jennifer A Halliday; Benjamin Lam; Steven Trawley; Sybil A McAuley; Leon A Bach; Morton G Burt; Neale D Cohen; Peter G Colman; D Jane Holmes-Walker; Alicia J Jenkins; Melissa H Lee; Roland W McCallum; Steve N Stranks; Vijaya Sundararajan; Tim W Jones; David N O'Neal; Jane Speight; Australian JDRF Closed-Loop Research Group

doi:10.1111/dme.15195

The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes

Diabet Med. 2024 Mar;41(3):e15195. doi: 10.1111/dme.15195. Epub 2023 Aug 23.

Authors

Christel Hendrieckx^{1

2

3}, Hanafi M Husin^{1

2}, Sienna Russell-Green^{1

2}, Jennifer A Halliday^{1

2

3}, Benjamin Lam^{1

2

4}, Steven Trawley^{2

5

6}, Sybil A McAuley^{5

6

7}, Leon A Bach^{8

9}, Morton G Burt^{10

11}, Neale D Cohen^{12

13

14}, Peter G Colman^{6

15}, D Jane Holmes-Walker^{16

17}, Alicia J Jenkins^{6

7

18}, Melissa H Lee^{6

7}, Roland W McCallum¹⁹, Steve N Stranks^{10

11}, Vijaya Sundararajan⁶, Tim W Jones^{20

21

22}, David N O'Neal^{6

7}, Jane Speight^{1

2

3}; Australian JDRF Closed-Loop Research Group

Collaborators

Australian JDRF Closed-Loop Research Group:
Barbora Paldus, Catriona M Sims, Richard J MacIsaac, Glenn M Ward, Kavita Kumareswaran, Stephen N Stranks, Joey Kaye, Jennifer Halliday, Steven Trawley, Andrzej Januszewski, Anthony C Keech, Sara Vogrin, Hanafi Mohamed Husin, Ben Lam, Philip M Clarke, Timothy W Jones, Elizabeth A Davis, Martin I de Bock, Mary B Abraham, Geoff R Ambler, Fergus J Cameron, Jan M Fairchild, Bruce R King

Affiliations

¹ School of Psychology, Deakin University, Victoria, Geelong, Australia.
² The Australian Centre for Behavioural Research in Diabetes, Victoria, Carlton, Australia.
³ Institute for Health Transformation, Deakin University, Victoria, Geelong, Australia.
⁴ Education Futures, University of South Australia, Adelaide, Australia.
⁵ The Cairnmillar Institute, Melbourne, Australia.
⁶ Department of Medicine, University of Melbourne, Melbourne, Australia.
⁷ Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne, Melbourne, Australia.
⁸ Department of Endocrinology and Diabetes, The Alfred, Melbourne, Australia.
⁹ Department of Medicine (Alfred Medical Research and Education Precinct), Monash University, Melbourne, Australia.
¹⁰ Southern Adelaide Diabetes and Endocrine Services, Flinders Medical Centre, Adelaide, Australia.
¹¹ College of Medicine and Public Health, Flinders University, Adelaide, Australia.
¹² Baker Heart and Diabetes Institute, Melbourne, Australia.
¹³ School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
¹⁴ School of Pharmacy, University of Queensland, Woolloongabba, Australia.
¹⁵ Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, Australia.
¹⁶ Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, Australia.
¹⁷ Sydney Medical School, University of Sydney, Sydney, Australia.
¹⁸ NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
¹⁹ Department of Diabetes and Endocrinology, Royal Hobart Hospital, Hobart, Australia.
²⁰ Department of Endocrinology and Diabetes, Perth Children's Hospital, Perth, Australia.
²¹ School of Paediatrics and Child Health, University of Western Australia, Perth, Australia.
²² Telethon Kids Institute, University of Western Australia, Perth, Australia.

PMID: 37562414
DOI: 10.1111/dme.15195

Abstract

Aims: To examine the psychometric properties of the Diabetes Management Experiences Questionnaire (DME-Q). Adapted from the validated Glucose Monitoring Experiences Questionnaire, the DME-Q captures satisfaction with diabetes management irrespective of treatment modalities.

Methods: The DME-Q was completed by adults with type 1 diabetes as part of a randomized controlled trial comparing hybrid closed loop (HCL) to standard therapy. Most psychometric properties were examined with pre-randomization data (n = 149); responsiveness was examined using baseline and 26-week follow-up data (n = 120).

Results: Pre-randomization, participants' mean age was 44 ± 12 years, 52% were women. HbA1c was 61 ± 11 mmol/mol (7.8 ± 1.0%), diabetes duration was 24 ± 12 years and 47% used an insulin pump prior to the trial. A forced three-factor analysis revealed three expected domains, that is, 'Convenience', 'Effectiveness' and 'Intrusiveness', and a forced one-factor solution was also satisfactory. Internal consistency reliability was strong for the three subscales ( $α$ range = 0.74-0.84) and 'Total satisfaction' $(α$ = 0.85). Convergent validity was demonstrated with moderate correlations between DME-Q 'Total satisfaction' and diabetes distress (PAID: r_s = -0.57) and treatment satisfaction (DTSQ; r_s = 0.58). Divergent validity was demonstrated with a weak correlation with prospective/retrospective memory (PRMQ: r_s = -0.16 and - 0.13 respectively). Responsiveness was demonstrated, as participants randomized to HCL had higher 'Effectiveness' and 'Total satisfaction' scores than those randomized to standard therapy.

Conclusions: The 22-item DME-Q is a brief, acceptable, reliable measure with satisfactory structural and construct validity, which is responsive to intervention. The DME-Q is likely to be useful for evaluation of new pharmaceutical agents and technologies in research and clinical settings.

Keywords: person-reported outcome; psychometric validation; treatment satisfaction; type 1 diabetes.

Publication types

Randomized Controlled Trial

MeSH terms

Adult
Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1* / drug therapy
Female
Humans
Male
Middle Aged
Patient Satisfaction
Prospective Studies
Psychometrics
Reproducibility of Results
Retrospective Studies
Surveys and Questionnaires

Substances

Blood Glucose

Abstract

Publication types

MeSH terms

Substances

Grants and funding